Published in Hepatitis Weekly, October 9th, 1995
"Our product pipeline is strong and extremely promising," R&D Chairman George Poste told a group of financial analysts at SB's Research and Development [R&D] Review Meeting. "It has the scale, balance and quality to put SmithKline Beecham at the top of our industry."
Poste and top SB R&D executives reviewed the company's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.